在治疗骨关节炎的纳米药物疗法方面取得了突破性进展
Jinfeng Liao1, Qingjia Gu2, Zheng Liu3
1Department of Dermatology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
Frontiers in pharmacology
|November 14, 2024
概括
骨关节炎 (OA) 治疗在药物输送方面面临挑战. 纳米医学为改善骨关节炎治疗提供了有针对性的,持续的交付,弥合了研究和临床使用之间的差距.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 是一个日益严重的全球健康问题,导致关节疼痛和残疾.
- 目前的OA治疗方法,如NSAID和葡萄糖胺,在有效的联合药物输送和持续的治疗效果方面存在局限性.
- 骨关节炎的慢性炎症和退行性需要创新的治疗策略.
研究的目的:
- 审查最近在治疗骨关节炎 (OA) 的纳米疗法方面的进展.
- 探索纳米医学的潜力,以克服当前OA治疗的挑战.
- 确定未来的研究方向,以优化对OA的纳米治疗策略.
主要方法:
- 对OA最近纳米疗法研究的文献综述.
- 纳米医学的优点分析:有针对性的输送,长时间的效果,生物可用性和减少的毒性.
- 对实验室发现和OA纳米治疗药物的临床应用之间的差距的检查.
主要成果:
- 纳米医学为OA治疗提供了有前途的优势,包括增强向性和生物可用性.
- 纳米颗粒显示出作为OA疗法的有效传递系统的潜力.
- 尽管有令人鼓舞的结果,但在OA纳米疗法研究和临床实施之间存在很大的差距.
结论:
- 纳米技术为骨关节炎管理提供了创新的解决方案.
- 需要进一步的研究来优化纳米治疗策略,并弥合临床应用的差距.
- 智能纳米医学具有显著的潜力,可以改善OA治疗结果.
相关概念视频
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Oral Drug Delivery Systems: Introduction
284
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
284


